发明名称 |
Delivery system for sustained release of a calcium-channel blocking agent |
摘要 |
A delivery system for sustained release of a calcium-channel blocking agent is adapted for introduction in the cerebrospinal fluid of a subject. The delivery system comprises a solid dispersion product of a calcium-channel blocking agent in a mixture of a (i) first poly(lactide-co-glycolide) having a molecular weight distribution centered around a first number average molecular weight Mn1 and a (ii) second poly(lactide-co-glycolide) having a molecular weight distribution centered around a second number average molecular weight Mn2, wherein Mn1 is in the range of from 2000 to 3000 g/mol and the ratio of Mn1/Mn2 is from 1.8 to 3.5. The delivery system is deposited in the vicinity of or adjacent to a blood vessel showing vasospasm or suspected of developing vasospasm. |
申请公布号 |
US9060986(B2) |
申请公布日期 |
2015.06.23 |
申请号 |
US201013500013 |
申请日期 |
2010.10.05 |
申请人 |
BDS Pharma GmbH |
发明人 |
Breitenbach Jorg;Liepold Bernd;Lefebvre Didier R.;Bossmann Steffen;Steitz Benedikt;Hölig Peter |
分类号 |
A61K31/4418;A61P25/00;A61K31/216;A61K9/00;A61K9/14 |
主分类号 |
A61K31/4418 |
代理机构 |
Saul Ewing LLP |
代理人 |
Saul Ewing LLP ;Lauro, Esq. Peter C. |
主权项 |
1. A delivery system for sustained release of nicardipine free base, a hydrate or solvate thereof, adapted for introduction into the cerebrospinal fluid of a subject, comprising a solid dispersion product of nicardipine free base, hydrate or solvate thereof, in a mixture of:
(i) a first poly(lactide-co-glycolide) having a molecular weight distribution centered around a first number average molecular weight Mn1 and a lactate:glycolate molar ratio of from 45:55 to 55:45; and (ii) a second poly(lactide-co-glycolide) having a molecular weight distribution centered around a second number average molecular weight Mn2 and a lactate:glycolate molar ratio in the second poly(lactide-co-glycolide) of from 45:55 to 55:45; wherein: Mn1 is in the range of from 2000 to 3000 g/mol and the ratio of Mn1/Mn2 is from 1.8 to 3.5; the nicardipine free base, hydrate or solvate thereof is molecularly dispersed in a monophasic mixture comprising the first poly(lactide-co-glycolide) and the second poly(lactide-co-glycolide); and the solid dispersion product is formed into a predetermined shape prior to introduction into the cerebrospinal fluid of said subject. |
地址 |
Graz AT |